CRT 2024
Symposium
EVENING SYMPOSIUM – Optimization of Therapy for CAD Patients with Pharmacotherapy [CME]
Birgit Vogel, MD
Assistant Professor of Medicine
Icahn School of Medicine at Mount Sinai, NY, NY
No relationships to disclose
C. Michael Gibson, MD
Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Disclosure(s): Absolutys: Shareholder (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); AstraZeneca Pharmaceuticals: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing); Beren Therapeutics: Consultant (Ongoing); Bioclinica: Consultant (Ongoing); BOEHRINGER INGELHEIM IT.SpA.: Consultant (Ongoing); Boston Clinical Research Institute: Consultant (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing); Boston Scientific: Consultant (Ongoing); Bristol Meyers Squibb: Consultant (Ongoing); Cardiovascular Research Foundation: Consultant (Ongoing); CeleCor Therapeutics: Consultant (Ongoing); CSL-Behring: Consultant (Ongoing), Grant/Research Support (Ongoing); Duke Clinical Research Institute: Consultant (Ongoing); Dyad Medical: Shareholder (Ongoing); Esperion: Consultant (Ongoing); EXCITE International: Advisor (Ongoing); Fortress Biotech: Consultant (Ongoing), Consultant (Ongoing), Shareholder (Ongoing), Shareholder (Ongoing); Gilead: Consultant (Ongoing); Inari: Consultant (Ongoing); Janssen Research & Development LLC: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Consultant (Ongoing), Grant/Research Support (Ongoing); MashUP MD: Consultant (Ongoing); MD Magazine: Consultant (Ongoing); Merck Pharmaceuticals: Consultant (Ongoing); MicroPort Medical: Consultant (Ongoing); MJH Life Sciences: Consultant (Ongoing); New Amsterdam Pharma: Consultant (Ongoing); nference: Shareholder (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); NovoNordisk: Consultant (Ongoing); PERT Consortium: Consultant (Ongoing); Pfizer: Consultant (Ongoing); PhaseBio: Consultant (Ongoing); plx pharma: Consultant (Ongoing); Revance Therapeutics: Consultant (Ongoing); Samsung: Consultant (Ongoing); SCAD Alliance: Consultant (Ongoing); SCAI: Consultant (Ongoing); SFJ: Consultant (Ongoing); Somahlution/Marizyme: Consultant (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing); Vecutra: Consultant (Ongoing); WebMD: Consultant (Ongoing); Woman As One: Consultant (Ongoing)
Sukhdeep S. Bhogal, MD
Interventional Cardiologist
Sovah Health
Roanoke, Virginia, United States
No relationships to disclose
Marc Cohen, MD
Chair of Medicine
Newark Beth Israel Med Ctr
Philadelphia, Pennsylvania, United States
No relationships to disclose
Neal S. Kleiman, MD, FACC, MSCAI
Medical Director, Cardiac Catheterization Laboratories
Houston Methodist DeBakey Heart and Vascular Center
Houston, Texas, United States
No relationships to disclose
Jennifer Rymer, MD
Interventional cardiologist
Duke, North Carolina, United States
Disclosure(s): Abiomed Inc: Contracted Research (Ongoing); Chiesi Inc: Advisor (Ongoing), Contracted Research (Ongoing); idorsia pharmaceuticals: Clinical Trial Investigator (Ongoing); Novo Nordisk: Clinical Trial Investigator (Ongoing), Contracted Research (Ongoing)
Daniela Trabattoni, MD
Director, Invasive Cardiology and Cardiac Defects Unit; Director, Women Heart Center
Centro Cardiologico Monzino, IRCCS, Milan, Italy
Milan, Italy
Disclosure information not submitted.